News
Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara ...
To close out the Festival of Biologics, Craig Burton and Giuseppe Randazzo from the Association for Accessible Medicines and ...
Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar bevacizumab for intravenous use. Jobevne, which is a recombinant ...
Biosimilars ... known biologics are powerful, relatively new anti-inflammatory drugs like Humira, which can help patients with everything from severe arthritis to ulcerative colitis. Related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results